AR048112A1 - Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor - Google Patents
Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolorInfo
- Publication number
- AR048112A1 AR048112A1 ARP050101093A ARP050101093A AR048112A1 AR 048112 A1 AR048112 A1 AR 048112A1 AR P050101093 A ARP050101093 A AR P050101093A AR P050101093 A ARP050101093 A AR P050101093A AR 048112 A1 AR048112 A1 AR 048112A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- compound
- alkoxy
- pain
- benzopiran
- Prior art date
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 239000004001 serotonin 1D antagonist Substances 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicacion 1: Uso de un compuesto que tiene actividad antagonista del receptor 5-HT1D, uso caracterizado porque es para la preparacion de una composicion farmacéutica para el tratamiento de dolor. Reivindicacion 2: Uso de un compuesto que tiene actividad agonista del receptor 5-HT1A y actividad antagonista del receptor 5-HT1D, uso caracterizado porque es para la preparacion de una composicion farmacéutica para el tratamiento de dolor. Reivindicacion 3: Uso de acuerdo con cualquiera de las reivindicaciones 1 o 2, caracterizado porque dicho compuesto es el compuesto que tiene la formula general (1), donde: R1 es alquilo C1-4, alcoxi C1-4, hidroxilo, alcoxi C1-4alquilo C1-4, pirrolidinilo, piperidinilo, morfolinilo, halogeno, ciano, trifluorometilo, amino, o amino mono- o disustituido donde los sustituyentes son alquilo C1-4, o alquil C1-4carbonilo; m tiene el valor 0, 1 o 2; R2 es alquilo C1-4, alcoxi C1-4, halogeno o trifluorometilo; n es 0 o 1, con la condicion de que (m + n) es al menos 1; R3 es hidrogeno, alquilo C1-3 o alquenilo C2-3; R4 es alquilo C1-4; y p tiene el valor 0, 1 o 2; y todos los estereoisomeros y sales farmacologicamente aceptables del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04101230 | 2004-03-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR048112A1 true AR048112A1 (es) | 2006-03-29 |
Family
ID=34928928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050101093A AR048112A1 (es) | 2004-03-25 | 2005-03-21 | Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050215567A1 (es) |
| EP (1) | EP1732558B1 (es) |
| JP (1) | JP2007530509A (es) |
| AR (1) | AR048112A1 (es) |
| AT (1) | ATE482707T1 (es) |
| CA (1) | CA2554074A1 (es) |
| PL (1) | PL1732558T3 (es) |
| PT (1) | PT1732558E (es) |
| TW (1) | TWI350753B (es) |
| WO (1) | WO2005092340A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1933870B (zh) * | 2004-03-23 | 2010-06-23 | 皇家飞利浦电子股份有限公司 | 自存储医用电极 |
| AR049478A1 (es) * | 2004-03-25 | 2006-08-09 | Solvay Pharm Bv | Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas. |
| US20060013874A1 (en) * | 2004-07-15 | 2006-01-19 | Solvay Pharmaceuticals B.V. | Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one |
| CA2763931A1 (en) * | 2009-06-10 | 2010-12-16 | Abbott Gmbh & Co. Kg | Use of substituted oxindole derivatives for the treatment and prophylaxis of pain |
| EP3523271B1 (de) * | 2016-10-10 | 2020-12-09 | Basf Se | Katalysatormodifikation mit alkalimetall-, erdalkalimetall- oder seltenerdmetallionen in der kontinuierlichen flüssigphasen-hydrierung von nitroverbindungen |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3586794T2 (de) * | 1984-12-21 | 1993-05-27 | Duphar Int Res | Arzneimittel mit psychotroper wirkung. |
| CA2004670A1 (en) * | 1988-12-08 | 1990-06-08 | Jan Hartog | Anxiolytically active piperazine derivatives |
| US5009895A (en) * | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
| FR2667068B1 (fr) * | 1990-09-26 | 1994-09-09 | Adir | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2670491B1 (fr) * | 1990-12-14 | 1993-02-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| EP0650964A1 (en) * | 1993-11-02 | 1995-05-03 | Duphar International Research B.V | 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives |
| US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
| NL9401572A (nl) * | 1994-09-27 | 1996-05-01 | Avebe Coop Verkoop Prod | Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten. |
| AU708053B2 (en) * | 1996-03-29 | 1999-07-29 | Duphar International Research B.V. | Piperazine and piperidine compounds |
| WO1999020621A1 (en) * | 1997-10-22 | 1999-04-29 | Eli Lilly And Company | ARYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS AND 5-HT1Dα ANTAGONISTS |
| DE19803131A1 (de) | 1998-01-28 | 1999-07-29 | Dolmar Gmbh | Kettenmediumpumpe für eine Motorkettensäge sowie Motorkettensäge mit einer solchen Kettenmediumpumpe |
| PA8469101A1 (es) | 1998-04-09 | 2000-09-29 | Pfizer Prod Inc | Ligandos azabiciclicos de receptores 5ht1 |
| US6376494B1 (en) * | 1998-06-15 | 2002-04-23 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| US6312717B1 (en) * | 1998-07-07 | 2001-11-06 | Bristol-Myers Squibb Company | Method for treatment of anxiety and depression |
| UA62015C2 (en) * | 1998-12-28 | 2003-12-15 | Pfizer Prod Inc | Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants) |
| GB0008563D0 (en) * | 2000-04-07 | 2000-05-24 | Cambridge Discovery Chemistry | Investigating different physical and/or chemical forms of materials |
| US20030008880A1 (en) * | 2001-05-02 | 2003-01-09 | Pfizer Inc. | 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity |
| WO2003082805A1 (en) * | 2002-03-28 | 2003-10-09 | Synthon B.V. | Low water-soluble venlafaxine salts |
| US20050215551A1 (en) * | 2004-03-25 | 2005-09-29 | Solvay Pharmaceuticals B.V. | 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders |
| AR049478A1 (es) * | 2004-03-25 | 2006-08-09 | Solvay Pharm Bv | Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas. |
-
2005
- 2005-03-21 AR ARP050101093A patent/AR048112A1/es unknown
- 2005-03-22 US US11/085,193 patent/US20050215567A1/en not_active Abandoned
- 2005-03-22 TW TW094108780A patent/TWI350753B/zh not_active IP Right Cessation
- 2005-03-23 WO PCT/EP2005/051328 patent/WO2005092340A1/en not_active Ceased
- 2005-03-23 CA CA002554074A patent/CA2554074A1/en not_active Abandoned
- 2005-03-23 AT AT05729786T patent/ATE482707T1/de active
- 2005-03-23 JP JP2007504418A patent/JP2007530509A/ja not_active Ceased
- 2005-03-23 PL PL05729786T patent/PL1732558T3/pl unknown
- 2005-03-23 PT PT05729786T patent/PT1732558E/pt unknown
- 2005-03-23 EP EP05729786A patent/EP1732558B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007530509A (ja) | 2007-11-01 |
| ATE482707T1 (de) | 2010-10-15 |
| TW200534847A (en) | 2005-11-01 |
| PL1732558T3 (pl) | 2011-03-31 |
| TWI350753B (en) | 2011-10-21 |
| EP1732558B1 (en) | 2010-09-29 |
| CA2554074A1 (en) | 2005-10-06 |
| WO2005092340A1 (en) | 2005-10-06 |
| EP1732558A1 (en) | 2006-12-20 |
| PT1732558E (pt) | 2010-12-23 |
| US20050215567A1 (en) | 2005-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
| ECSP105253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
| BR0309397A (pt) | Derivados de n-[fenil(piperidin-2-il)metil]benzamida, sua preparação e sua aplicação em terapia | |
| AR066583A1 (es) | Derivados de 3,3-espiroindolinona | |
| ES2195785B1 (es) | Nuevos derivados de piridazin-3(2h)-ona. | |
| AR054799A1 (es) | Derivados de oxindol | |
| ECSP055582A (es) | Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor | |
| EA200970461A1 (ru) | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ | |
| NI200600257A (es) | Nuevos compuestos. | |
| CY1104993T1 (el) | 4-(πιπεριδυλ- και πυρρολιδινυλ-αλκυλ-ουρεϊδο)-κινολινες ως ανταγωνιστες του υποδοχεα ουροτασινης ii | |
| CY1116183T1 (el) | Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης | |
| MX2024013019A (es) | Compuestos de heteroarilo para el tratamiento del dolor | |
| UY27851A1 (es) | Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
| UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
| BRPI0417161A (pt) | compostos, composições farmacêuticas, e, uso de um composto | |
| UY28356A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos | |
| AR013503A1 (es) | Una combinacion de un inhibidor de la monoamina oxidasa y un antagonista o agonista parcial selectivo de h5-ht(1b), formulacion farmaceutica, usos ymetodo de preparacion | |
| AR073891A1 (es) | Derivados de isoquinolinona antagonistas de receptores nk3, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de psicosis, alzheimer y otras enfermedades. | |
| UY28357A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos | |
| AR024840A1 (es) | Compuestos de 5ht1 para terapia antidepresiva; composiciones farmaceuticas y su uso en la preparacion de medicamentos. | |
| AR037611A1 (es) | Compuestos derivados de amino-tetralina, su uso, un procedimiento para su preparacion y composiciones farmaceuticas que los comprenden | |
| MX2007003105A (es) | Derivados de bencimidazol, composiciones que los contienen, sus preparaciones y sus usos i. | |
| BRPI0411308A8 (pt) | Composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
| PE20060632A1 (es) | Derivados de arilsulfonilestilbeno como antagonistas de los receptores 5-ht2a | |
| UY28535A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |